SCAMICOS 2010.
Methods | Site: BK popliteal and distal (the latter not included in this review) Study design: multicentre RCT Method of randomisation: concealed randomisation using sealed envelopes in blocks of 16 per centre Blinding: unblinded, intention to treat Exclusions post randomisation: 3 (1%) Losses to follow up: 0 (0%) Protocol violations: 3 (1 ‐ suitable vein available, 1 ‐ distal reconstruction below popliteal artery, 1 ‐ crossover from non‐collar to collar group) |
|
Participants | Country: 29 centres in Sweden and 3 in Denmark Setting: hospital No. of participants: 202 (87 PTFE, 115 PTFE with vein collar) Age (median): 79 yrs in PTFE group, 76 yrs in PTFE with collar group Gender: 77 males, 122 females; 3 excluded Inclusion criteria: rest pain, tissue loss Exclusion criteria: no suitable distal anastomotic target, distal anastomosis AK or below anterior tibial origin for BK popliteal group, or below‐ankle for distal group |
|
Interventions | Gore or Impra PTFE graft with or without distal vein cuff, diameter not specified (diameter at discretion of operating surgeon) | |
Outcomes | Primary patency; secondary patency; amputation; death | |
Notes | No consistent anticoagulation protocol | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | No description of randomisation sequence generation technique |
Allocation concealment (selection bias) | Low risk | Envelope selected at random after confirmation of suitable target vessel |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Operative blinding impossible in this type of trial |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Outcome assessors and patients not obviously blinded |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Only 3 patients had missing follow‐up data |
Selective reporting (reporting bias) | Low risk | All stated outcomes reported |
Other bias | Unclear risk | No consistent anticoagulation protocol |